A randomised controlled study of combination therapy in rheumatoid arthritis (RA) patients with a suboptimal response to sulphasalazine
Completed
- Conditions
- Rheumatoid arthritisMusculoskeletal Diseases
- Registration Number
- ISRCTN65477168
- Lead Sponsor
- Arthritis Research Campaign (ARC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Male or female
2. Age 18 - 75 years
3. Onset of disease after age 16
4. Disease duration less than 5 years
5. Active inflammatory arthritis which is defined as six or more swollen joints plus two of the following:
5.1. Morning stiffness more than 45 minutes
5.2. Nine or more tender joints
5.3. Erythrocyte Sedimentation Rate (ESR) more than 28 mm/h
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method